| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000022896 |
| Receipt No. | R000026342 |
| Public title | An exploratory study in developing a diagnostic method for rheumatic diseases using a photoacoustic imaging system |
| Date of disclosure of the study information | 2019/09/13 |
| Last modified on | 2019/03/13 (Ver. 7) |
| Basic information | ||
| Public title | An exploratory study in developing a diagnostic method for rheumatic diseases using a photoacoustic imaging system | |
| Acronym | An exploratory study in developing a diagnostic method for rheumatic diseases using a photoacoustic imaging system | |
| Scientific Title | An exploratory study in developing a diagnostic method for rheumatic diseases using a photoacoustic imaging system | |
| Scientific Title:Acronym | An exploratory study in developing a diagnostic method for rheumatic diseases using a photoacoustic imaging system | |
| Region |
|
|
| Condition | ||
| Condition | Rheumatic diseases (rheumatoid arthritis, polymyalgia rheumatica, palindromic rheumatism, RS3PE syndrome, Sjogren's syndrome, psoriatic arthritis, seronegative spondyloarthropathy, systemic connective tissue disease). | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To assess the imaging capability of synovitis (blood flow in the synovial hypertrophy) in joints, synovial bursa or tendon sheath using a photoacoustic imaging system for undifferentiated arthritis and rheumatic diseases. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Contrast and volume of photoacoustic images corresponding to synovitis (blood flow in the synovial hyperplasia) in joints, synovial bursa or tendon sheath for undifferentiated arthritis and rheumatic diseases. |
| Key secondary outcomes | Incidence of adverse events by using the photoacoustic imaging system.
(Final monitoring is conducted within 90 days after intervention) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | Photoacoustic Imaging
(Use of the device is for up to three days) |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Patients with undifferentiated arthritis and rheumatic disease (rheumatoid arthritis, polymyalgia rheumatica, palindromic rheumatism, RS3PE syndrome, Sjogren's syndrome, psoriatic arthritis, seronegative spondyloarthropathy, systemic connective tissue disease) those who were enrolled in KURAMA cohort study.
2. Patients who aged over 20 years and older at the time of informed consent. 3. Patients who have agreed to participate in this study from their own free will with document consents. |
|||
| Key exclusion criteria | 1. Pregnant and lactating patients
2. Patients who takes photosensitizer for photodynamic therapy 3. Patients with a cardiac pacemaker 4. Patients who are in poor general status 5. People who have any following complications in assessment body parts: Open wounds, excoriations, acnes, surgical wounds. Infected wounds. Infections. Neurological diseases and orthopedic disorders in which it is impossible to keep sitting or standing position. 6. People who have any following history of disorders: Mental disorders. Dementia. 7. Patients who are judged ineligible to enroll into this clinical study by the investigator or the sub-investigators due to communication difficulty, limitations in taking examination position and other reasons. |
|||
| Target sample size | 40 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Graduate School of Medicine Kyoto University | ||||||
| Division name | Department of Orthopaedic Surgery | ||||||
| Zip code | 606-8507 | ||||||
| Address | 54 Shogoin Kawara-cho, Sakyo-ku, Kyoto, Japan | ||||||
| TEL | 075-751-3366 | ||||||
| seikei@kuhp.kyoto-u.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Graduate School of Medicine Kyoto University | ||||||
| Division name | Department of the Control for Rheumatic Diseases | ||||||
| Zip code | 606-8507 | ||||||
| Address | 54 Shogoin Kawara-cho, Sakyo-ku, Kyoto, Japan | ||||||
| TEL | 075-751-3366 | ||||||
| Homepage URL | |||||||
| morifuru@kuhp.kyoto-u.ac.jp | |||||||
| Sponsor | |
| Institute | Kyoto University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Cabinet Office |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | Canon Inc. |
| Name of secondary funder(s) | Canon Inc. |
| IRB Contact (For public release) | |
| Organization | Kyoto University Hospital Ethics Committe |
| Address | Konoe-cho, Yoshida, Sakyo-ku, Kyoto, Japan |
| Tel | 0757534680 |
| ethcom@kuhp.kyoto-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 14 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026342 |